Global Nuclear Medicine Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Product Type Coverage, By Application Coverage, By End User Coverage, By Geographic Coverage and By Company)
Published Date: Dec 2023 |
Format:
| No. of Pages: 206
As of 2022, the global nuclear medicine market was valued at approximately US$5.2 Bn and is expected to grow at a CAGR of more than 11% over the forecast period.
The market is primarily driven by increasing incidences of cancer, rising awareness about early disease diagnosis, and advancements in radiopharmaceuticals and imaging technologies.
North America is anticipated to be the leading market due to a high prevalence of chronic diseases, followed by Europe and the Asia Pacific region, where the market is expected to witness significant growth.
Regulatory complexities, shortage of radioisotopes, and high infrastructure costs pose challenges, along with concerns about radiation exposure, limiting widespread adoption.
Major companies are focusing on strategic collaborations, acquisitions, and product innovations to strengthen their market presence, with an emphasis on expanding their product portfolios and global reach.
Buy now
Quality assured
Report Description
Research Methodology
